Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography
- 29 February 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Esophagus
- Vol. 43 (2), 144-151
- https://doi.org/10.1007/s00535-007-2132-y
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Clinical diagnostic criteria of autoimmune pancreatitis: revised proposalThe Esophagus, 2006
- Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and Its Cost-EffectivenessAnnals of Surgery, 2005
- F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective studyJournal of Gastrointestinal Surgery, 2005
- Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) —Usefulness and limitations in “clinical reality”—Annals of Nuclear Medicine, 2003
- Pancreaticoduodenectomy (Whipple Resections) in Patients Without MalignancyThe American Journal of Surgical Pathology, 2003
- High Serum IgG4 Concentrations in Patients with Sclerosing PancreatitisThe New England Journal of Medicine, 2001
- Autoimmune Pancreatitis With F-18 Fluoro-2-deoxy-D-Glucose PET FindingsClinical Nuclear Medicine, 1999
- Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-d-glucose for the differentiation of chronic pancreatitis and pancreatic cancerBritish Journal of Surgery, 1999
- Fluorine-18 fluorodeoxyglucose positron mission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 casesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996